TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15,487
|
13,979
|
13,267 |
| Financial expenses |
48
|
53
|
27 |
| Earnings before taxes |
663
|
563
|
269 |
| Total assets |
5,220
|
4,468
|
4,332 |
| Current assets |
4,210
|
3,534
|
3,239 |
| Current liabilities |
1,244
|
970
|
1,059 |
| Equity capital |
2,925
|
2,534
|
2,234 |
| - share capital |
84
|
89
|
95 |
| Employees (average) | 41 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.0%
|
56.7%
|
51.6% |
| Turnover per employee | 324 | ||
| Profit as a percentage of turnover |
4.3%
|
4.0%
|
2.0% |
| Return on assets (ROA) |
13.6%
|
13.8%
|
6.8% |
| Current ratio |
338.4%
|
364.3%
|
305.9% |
| Return on equity (ROE) |
22.7%
|
22.2%
|
12.0% |
| Change turnover |
2,222
|
1,555
|
-2,116 |
| Change turnover % |
17%
|
13%
|
-14% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.